2 Patents
- US123310992025VEGF Antagonist Formulations Suitable for Intravitreal Administration
Regeneron Pharmaceuticals, Inc.
0 cites - US117320242023VEGF Antagonist Formulations Suitable for Intravitreal Administration
Regeneron Pharmaceuticals, Inc.
0 cites